Persuasive Essay On Transgenders - 1524 Words

Female sports are being ruined, because males are identifying themselves as females and competing with an unfair advantage. The biological men are causing a big problem around the world. They are breaking records and winning competitions in wrestling, weightlifting, track, softball, volleyball, basketball, mixed martial arts, and more. Transgenders competing in women’s sports ask for equality, but it is proven that men are bigger and stronger than women, so they are making the sports unfair for the biologically born women. You are either born as a male or a female, with this being said, you get all the attributes that come with that. Everyone identified as a transgender needs to realize that they cannot change their sex. There have been†¦show more content†¦More hemoglobin allows the muscles to work harder for a longer period of time. The higher aerobic capacity, gives men the advantage over women when running events over 800 meters. Men also have longer and stronger bones, they are denser and have stronger ligaments, which make men less prone to injury. Longer bones allow for men to be taller and have greater leverage and because the bones are also stronger, they help support their larger body frame. This can be a huge advantage when competing in sports such as wrestling, weightlifting, football, and mixed martial arts. On another occasion of events a mixed martial arts competitor, claimed to be overpowered when she fought a transgender female. She announced that her opponent had a stronger grip that was beyond anything she had ever gone against. A male has bigger hands and shoulders, they are mechanically better, so they can throw harder and faster punches. The transgender managed to knock out the female within the first two minutes of the first round. I am not surprised as it is basically a man fighting a woman. Many times lawsuits are filed against organizations, because of their rules that don’t allow transgender women to play. A law suit was once filed against the International Women’s Football League, because a transgender was denied the right to play for them. The league will only accept biologically born female players, since they believe that Transgenders have an advantage. TheShow MoreRelatedPersuasive Essay On Transgender Women1891 Words   |  8 Pagesthan what a man would make. When it comes to transgender women the situations are much difficult and more complex. Conversely when people hear the term â€Å"transgender† some individuals have a lot to say and there’s many debates on this topic. Society does not believe that transgender women are defined as a woman. Every year the number of transgender women increases drastically and the suffrage they go through worsen as the days go by. Nevertheless, transgender women deal with people arguing about theirRead MoreGender Dysphori Misunderstood.1779 Words   |  8 Pages Gender Dysphoria: Misunderstood Haley Harrison Ethics 212: Professor Cockerham Research/Critical Thinking Essay December 5, 2015 Gender Dysphoria is a name given to the condition of children who express a gender that is opposite of their biologically given gender. Children and teens who present and verbalize the desire to be of the opposite gender for at least six months are then diagnosed and treated medically. This issue is ethically controversial due to many parents, medicalRead MoreGender Identity As An Axis Of Social Order1611 Words   |  7 PagesSweden in 2012 when a third gender-neutral pronoun hen was proposed as an addition to the already existing Swedish pronouns for she(hon) and he(han). The pronoun ‘hen’ can be used both generically, when gender is unknown or irrelevant, and as a transgender pronoun for people who categorize themselves outside the gender dichotomy. The aim is to enhance the language by making it easier to speak about a person without specifying their gender. Swedish speakers are trying to promote the use of ‘hen’ asRead MoreGender And Gender : A Sociolo gical Perspective On A Clearer Perception Of The Philosophy And Professional Objectives2099 Words   |  9 PagesThis essay explores gender in a clearer perception of the philosophy and professional objectives to develop a foundation for deeper analytical studies. The assumptions made that gender is biologically determined is rebutted when applied to the case of intersexuality and transgender. As gender is a prà ©cised ecclesiastical constructionist paradigm and while humans are born with a certain sex orientation, it does not determine the way one dresses or behaves (DeLamater19998, pp. 15-16). This essay thenRead MoreStephen P. Robbins Timothy A. Judge (2011) Organizational Behaviour 15th Edition New Jersey: Prentice Hall393164 Words   |  1573 PagesCommunication 341 †¢ Nonverbal Communication 341 Organizational Communication 342 Formal Small-Group Networks 343 †¢ The Grapevine 343 †¢ Electronic Communications 345 †¢ Managing Information 349 Choice of Comm unication Channel 350 xiv CONTENTS Persuasive Communications 351 Automatic and Controlled Processing 351 †¢ Interest Level 352 †¢ Prior Knowledge 352 †¢ Personality 352 †¢ Message Characteristics 352 Barriers to Effective Communication 353 Filtering 353 †¢ Selective Perception 353 †¢ Information

The Declaration Of Biafra Speech - 1428 Words

This Declaration of Biafra Speech as retrieved on 15 August 2008 raises the issue of ‘Self-Determination’. Self-determination is the principle in international law that allows nations the right to freely choose their sovereignty and international status without external interference. The right of nations to self-determination is a cardinal principle in modern international law, binding, as such, on the United Nations as an authoritative interpretation of the Charter’s norms. It states that nations based on respect for the principle of equal rights and fair equity of opportunity have the right to freely choose their sovereignty and international political status with no external compulsion or interference which can be traced back to the†¦show more content†¦Further feelings of injustice were caused by Nigeria, changing its currency so that Biafra supplies of pre-war Nigerian currency were no longer honoured, at the end of the war; only  £20 was given to any easterner despite whatever amount of money he or she had in the bank. This was applied irrespective of their banking in pre-war Nigerian currency or Biafra currency. This was seen as a deliberate policy to hold back the Igbo middle class, leaving them with little wealth to expand their business interests. The total dead on the Biafra side is estimated to be between 1-3 million dead with hundreds of thousands injured and millions more refugees. While the Nigeria oil boom of the 1970 s went some way to ameliorating the pains brought about by the war, the ethnic tensions that caused the war still haunt Nigerian politics till today. The question is, ‘Why was Biafra denied their right to self-determination, bearing in mind that genocide existed then’? From 1999 to the present day, the indigenous people of Biafra have been agitating for independence to revive their country. They have registered a human rights organisation known as Bilie Human Rights Initiative both in Nigeria and in the United Nations to advocate for their right to self-determination and achieve independence by the rule of law. The United Nations respect the right of all peoples to choose the form of government under which they will live, and theyShow MoreRelatedEssay on Human Rights, War and Terrorism1226 Words   |  5 Pagesthe Universal Declaration of Human Rights 1948 provides for this right. The violation of this right goes unnoticed but it is the first step to the violation of the other rights. 2. The right to self-determination: This is the most controversial of all this rights. It is easier obtained with the support of super powers and readily crushed with the lack of consent from the super powers. The people of Bangladesh were given this right in 1971 and the Biafra people in NigeriaRead MoreLearning for the Cuban and Nigerian Revolution2010 Words   |  9 Pagesexpression, torture, and a laundry list of offenses, the Castro leadership continues to follow in the footsteps of their predecessor. Cuba is still held under close scrutiny by the international stage and though they have violated the Universal Declaration of Human Rights from the U.N, they potentially could alter their political climate to avoid future conflict. Cuba has a long history of corruption in its leadership from President Prio’s political factions, dictatorship from Batista, and now humanRead MoreHistory of Ife/Modekeke Crisis4543 Words   |  19 Pagespeople were often depicted with large heads because the artists believed that the Ase was held in the head, the Ase being the inner power and energy of a person. Their rulers were also often depicted with their mouths covered so that the power of their speech would not be too great. They did not idealize individual people, but they tended rather to idealize the office of the king. The city was a settlement of substantial size between the 9th and 12th centuries, with houses featuring potsherd pavements

Challenges of Canadian Pharmaceutical-Free-Samples for Students

Question: Write an Essay on Challenges of Canadian Pharmaceutical Policy. Answer: Canadian pharmaceutical policy involves both provincial and federal levels of Government. The federal Government is involved in the manufacturers intellectual property rights, initial approval, prescription drugs labeling and looking after the competitive nature of the overall market. The provincial government on the other hand has jurisdiction and responsibility of the healthcare facilities funding, including the pharmaceuticals (Daw Morgan, 2012). The federal government regulates the prices of drugs, but does not buy the drugs. The provincial government has no power over market pricing and competitiveness (Ridic, Gleason Ridic, 2012). However, one issue that is associated with pharmaceutical policies is the non-disclosure of payments to doctors by the drug or pharmaceutical companies (Stamatakis, Weiler Ioannidis, 2013). A lack of transparency was observed, when the pharmaceutical companies made payment disclosures. It is necessary for the federal government to take immediate responsibility of the issue and ask the companies to provide a list of the doctors who received payments from the drug companies and what were the amounts paid. This policy research essay will provide information about Canadian pharmaceutical policies and provide analysis of the above mentioned issue. This essay at first determine the history of the policy challenge, provide an overview of the current policies and provides recommendations from the research carried out. Pharmaceutical or drug companies develop relationships with physicians, doctors and other healthcare workers in order to generate business through them by utilization of a variety of processes (Bending, 2015). These include giving gifts, personal services, entertainment and even payments. These activities have a significant potential for generation of abuse and fraud (Mackey Liang, 2012). Moreover, the companies do not disclose these payments made to the doctors. Patients also remain in the dark about the illegal payments of pharmaceutical companies to doctors. This results in prescribing drugs by the doctors that are highly expensive and sometimes are not associated with proper approvals by the FDA (Choi, 2015). This affects the patients monetarily as well as unapproved drugs may cause harm to the patients in the long run. Moreover, a non-disclosure of such payments is considered unethical and also prevents the involvements of patients in clinical trials. There are a number of evidences that can be unearthed from the past regarding physician payments that are not disclosed by pharmaceutical companies. Both companies as well as medical practitioners believe that development of relationship between the medical professionals and pharmaceutical companies will help in the development of academic research. These academic research can later be translated into drug development (Board, 2012). However, various malpractices are carried out, where the drug companies pay the medical professionals like doctors but do not disclose these payments to the government and the public in general. A certain level of transparency is to be maintained so that the public also come to know about the dealings between these organizations. Previously, such events have taken place and are described here. In 1976, in Canada, there were reports of high costs related to pharmaceutical industry. Moreover, there were reports of pharmaceutical companies spending large amo unts of money not only on research but also on promotional activities, which included undisclosed payments to physicians. Various Canadian pharmaceutical companies who had provided payments to doctors included AbbVie Corp, GSK Canada, Merck Canada, Novartis Pharmaceutical Canada, Eli Lilly Canada, among others (A Almeman, 2017). Various psychiatrists like Charles Nemeroff and Alan Scatzberg were charged for taking undisclosed payments from various pharmaceutical companies. In April, 2011, Johnson and Johnson were charged of bribing doctors in Poland, Greece and Romania to buy the drugs manufactured by them. They spent 7.6 million dollars on providing travel grants for doctors. The company earned 3.5 million dollars profit from product sales through bribery (Www.sec.gov, 2017). Other incidents that occurred in the past include Eli Lilly, who was charged in 2012 of paying government officials in order to increase sales in China, Poland, Brazil and Russia. Others include Pfizer, charged for carrying out illegal payments in various Asian and European countries. In 2014, Endo Pharmaceuticals were charged for mis-promotion of Lidoderm, which is a local anesthetic. GlaxoSmithKline was also charged for selling drugs not approved by the FDA (Www.ipsen.com, 2017) Past approaches that were carried out to rectify the challenge faced in the health sectors included restriction of interactions between doctors and representatives of the pharmaceutical companies. Moreover, payments if made would have to be disclosed to the Government and reported. The aim of the approach was to prevent the pharmaceutical industry to modulate the prescribing behaviors of the doctors. In the 1960s, there were various debates regarding the appropriateness in the relationships of the pharmaceutical companies and doctors. In 1991, American Medical Association (AMA) issued various rules and guidelines regarding undisclosed payments and gifts that are given to clinicians, physicians and doctors by the pharmaceutical companies (Breault, Shenson Dugdale, 2015). From that time onwards, attention was paid to pharmaceutical marketing methods as a result of the rise of marketing strategies and increased drug prices. According to the AMA, gifts valued below 100 dollars are allow ed if they provide patient benefit and associated with a doctors practice. Moreover, meals can be funded to doctors by pharmaceutical companies if it is modest and is carried out in association with an educational or academic component (DuBois et al., 2012). The guidelines effective from 2009, also prevent non-educational or practice associated gifts like pens to be given to clinicians, physicians and doctors. However, the guidelines permitted the pharmaceutical companies to provide meals, educational gifts and drug samples which are less than 100 dollars to the doctors. The Association of American Medical Colleges (AAMC) endorsed policies that describe the public disclosure of relationships between pharmaceutical companies and doctors (Reddi, 2013). However, the limitations associated with these policies are that the AMA ethics guidelines are not followed by majority of the doctors. Moreover, according to the guidelines, the physicians can receive gifts that are worth less than 100 dollars. However, small value gifts can also influence the behavior practice of the physicians. Thus, the Government has to play an essential role in reducing such promotional marketing strategies used by the pharmaceutical companies. Improvements of payment transparency between clinicians and pharmaceutical companies have been a focus for the Government. The approaches used can be defined as disclosure of physician payments and gifts, ban on physician gifts, Limiting the sale of prescribing data for marketing purpose, licensing of pharmaceutical sales representatives and public funding of academic detailing programs(Patwardhan, 2016). Various state lawmakers have proposed numerous laws, which can be applied for reducing the effects of gifts or payments made by pharmaceutical organizations in the physicians practices. Thus, Government regulations provide a legal enforcement credibility that forces the pharmaceutical companies to comply with the Government regulations. However, there are limitations like the regulated organizations can find loopholes in the law and can flout them by challenging the validity of such enforcements. Current approaches that were carried out to rectify the challenge includes the involvement of the Securities and Exchange Commission, where the pharmaceutical companies involved in bribing doctors were asked to give detailed accounts of the payments made to the respective doctors. This information was asked to be provided in the company website. This will enable the public to view the dealings made between the pharmaceutical companies and the healthcare members like doctors, general practitioners, among others. In 2012, the Australian Competition and Consumer Commission (ACCC) demanded Medicines Australia to include payment disclosures involving doctors and pharmaceutical companies (Www.accc.gov.au, 2017). The respective transparency principle was applicable to all the therapeutic companies. Moreover, it also included the health professionals like clinicians, doctors, among others. Other approaches involve those made by the United States, like the US Physician Payment Sunshine Act, w hich requires various pharmaceutical companies to provide details of all the payments to the Centre for Medicare and Medical Services (CMS) (Www.ama-assn.org, 2017). Moreover, apart from payments, other transfers of high value like gifts or travel grants were also included. All the data collected were eventually be reported to the public to maintain transparency in the dealings of the pharmaceutical world. In Ontario Canada, the Government is planning to enforce rules and regulations that would force the pharmaceutical companies to disclose the payments made by them to the doctors. Other approaches of the current world include fines and criminal penalties, inclusion of tax policies, among others (Www.cbc.ca, 2017). Such a proposed legislation will enable the public including the patients to get proper information that would empower them to make better decisions regarding healthcare. It also enables patients to either accept or reject a prescribed drug and also change doctors if need ed. Moreover, a central online database will enable any person to view the dealings between medical organizations and pharmaceutical companies. Some regulatory strategies towards undisclosed payments involve command and control, self regulation, market enhancing and incentives control, disclosures and liabilities and rights laws. These help to either determine the offenders or impose penalties one caught. Command and control implies to criminal sanctions and states that such unofficial payments by pharmaceutical organizations to doctors and other healthcare facilities, are not acceptable and severe penalties are liable to be enforced if discovered. The relevance of the strategy towards healthcare sector involves standards of behaviour and other codes of conduct, which is to be followed to avoid criminal penalties. However, the limitation of this strategy is that the penalties function only when the incentives are sufficient and the enforcing of such strategy depends on the independence of the regulator. The next strategy is self-regulation, which involves regulations by professional medical associations. The relevance of thi s strategy is that the medical association itself designs some standards or codes of conduct which is to be followed by all members of that medical association. However, the limitations involve that the incentive should be high enough to implement possible penalties (Www.researchgate.net, 2017). Another strategy is the market enhancing and incentives controls, which provide appreciation and inducements when regulations and general codes of conducts are followed. are followed. This helps to legalize private practice by doctors. Legalization of private practice is one way of increasing competition in the health sectors as it provides a wide range of options for the patients to choose from. Moreover, it also opens up new income sources for the practitioners. This practice in turn will increase the benefits of the doctors and thereby prevent acceptance of unofficial payments. This strategy, however, has limited scope because the attention of the doctors will be shifted from the benefits of the public health sector to private practices for their own benefits. However, such a strategy can be applied to those health facilities, where the competitions are very weak (Mahmoud Mahmoud, 2016). The most important strategy is disclosure, which involves identifying the offenders involved in carrying out undisclosed payments. This puts pressure on the offenders as it affects the reputations of both the pharmaceutical companies and the doctors. Policy makers if disclose the names of the hospitals that are the best and worst with respect to following a code of conduct, those who are the worst will feel the pressure to improve their standards. It will also help to generate list of healthcare facilities like hospitals taking undisclosed payments. The importance of this approach is that public surveys can help to determine the amount of money paid and to whom and the necessary reasons for the payment. However, there are limitations of this strategy, which includes the acceptance of the public that payments are not beneficial. The public may think that good payments may increase their access to better doctors, or chance of getting good health facilities, which in turn can give rise to unofficial payments to doctors by patients themselves (Loewenstein, Sah Cain, 2012). Lastly, the right and liabilities law provides a standard code of law protected consumer or patient rights. This may in turn help to limit the requirements of unofficial payments. Thus, customer rights can be maintained by imposing civil action or criminal prosecution against those who do not follow the legal system. However, limitations of such a strategy involves that such a strategy places the responsibility of the regulation on an individual and not the organization in general. Moreover, in order to avoid getting criminally prosecuted, private settlements of unofficial payments will be more attractive (Jahangiri Aryankhesal, 2017). There are various means to obtain data regarding the pharmaceutical policy issues. The data was gathered by traditional means, which included interviews with patients, healthcare facility members like general practitioners, doctors, clinicians and also the pharmaceutical company representatives. Moreover, other means include government websites, which provide information about the amount of money paid by pharmaceutical organizations to healthcare workers like doctors. The pharmaceutical company websites also give information about how much money they have paid to the doctors. Moreover, by searching a doctors name, the websites provide information about the nature of the payments. The websites break down the payments into consulting fees, travel and stay expenses, research fees, foods, beverages and grants. Moreover, data can be obtained from government reports, news articles, literature reviews, and journal articles. Proper analysis of the data obtained from various resources revealed that a close relationship exists between doctors and pharmaceutical industries. These relationships are mainly based on finances. However, such payments are usually not official and are not disclosed. However, in the recent times, disclosures of these payments are carried out. These financial collaborations encompass research funding to personal investments, direct physician payments like travel grants, gifts, meals, among others. The organizations should remain transparent in order to provide the information about such dealings to the general public. Moreover, such malpractices reduce the credibility of both the medical organizations as well as that of the pharmaceutical companies. Various strategies have been implied by the Government, however, the companies find out various loop holes in the policies and guidelines thereby protecting themselves from criminal prosecutions. In the current age, drug companies who ar e found to be involved in such activities were charged. Moreover, recent reforms force the drug companies to disclose the payments in their annual reports or the websites. Such undisclosed payments are a type of marketing strategy that the companies adapt in order to make the physicians favor the prescription of the drugs made by the company. However, this may cause the patients to buy certain drugs, which are very expensive even though other cheaper and effective options are available in the market (Kalotra, 2014). Moreover, some companies try to promote the drugs, which have not been clinically approved by organizations like the FDA. These may have serious implications as use of such drugs may lead to serious health consequences concerning the health of patients. Such mal practices when discovered not only tarnishes the reputations of the companies and the medical organization but also the doctors in general. It also decreases the faith of the public including the patients in the healthcare system. The patients pay a huge amount of money, in not only doctor consultations and treatments but also to buy medicines, which are prescribed by doctors. It is necessary for bringing about new policies by the Governments as well as the medical organizations that define a series of code of conducts to be followed by the companies and the hospitals. A breach of such conduct should entitle to criminal prosecutions and legal actions. The Ontario Government has taken such a drastic step, where they have said that a bill will be generated that will require public disclosure of unofficial payments made to healthcare employees like doctors by the pharmaceutical companies. Thus, it can be concluded that curbing of financial dealings between companies and healthcare sectors are essential in order to prevent wastage of large amounts of money in promotional strategies. Such reforms may also help to decrease the costs of drugs in the future, which are at an ever-rising stage. References A Almeman, A. (2017).Direct-To-Physician Advertising and Antibiotic Utilization in Upper Respiratory Tract Infection: A Critical Analysis. Retrieved 2 November 2017, from https://www.omicsonline.org/direct-to-physician-advertising-and-antibiotic-utilization-in-upper-respiratory-tract-infection-a-critical-analysis-2153-2435.php?aid=16347view=mobile Bending, Z. J. (2015). Reconceptualising the doctorpatient relationship: Recognising the role of trust in contemporary health care.Journal of bioethical inquiry,12(2), 189-202. Board, E. S. C. (2012). Relations between professional medical associations and healthcare industry, concerning scientific communication and continuing medical education: a policy statement from the European Society of Cardiology.Revista Portuguesa de Cardiologia (English Edition),31(7), 529-538. Breault, J. L., Shenson, D., Dugdale, L. S. (2015). Ethics of physician relationships with industry.Hospital Medicine Clinics,4(4), 565-580. Choi, R. (2015). Increasing Transparency of Clinical Trial Data in the United States and the European Union.Wash. U. Global Stud. L. Rev.,14, 521. Daw, J. R., Morgan, S. G. (2012). Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010.Health Policy,104(1), 19-26. DuBois, J. M., Anderson, E. E., Carroll, K., Gibb, T., Kraus, E., Rubbelke, T., Vasher, M. (2012). Environmental factors contributing to wrongdoing in medicine: A criterion-based review of studies and cases.Ethics behavior,22(3), 163-188. Jahangiri, R., Aryankhesal, A. (2017). Factors Influencing on Informal Payments in Healthcare Systems: A Systematic Review.Medical Ethics Journal,11(40), 73-92. Kalotra, A. (2014). MARKETING STRATEGIES OF DIFFERENT PHARMACEUTICAL COMPANIES.Journal of Drug Delivery and Therapeutics,4(2), 64-71. Loewenstein, G., Sah, S., Cain, D. M. (2012). The unintended consequences of conflict of interest disclosure.Jama,307(7), 669-670. Mackey, T. K., Liang, B. A. (2012). Transparency in Physician-Industry Relationships: State and Federal Efforts.AJSP: Reviews Reports,17(4), 144-147. Mahmoud, M. A., Mahmoud, M. A. (2016). Consumer trust and physician prescription of branded medicines: an exploratory study.International Journal of Pharmaceutical and Healthcare Marketing,10(3), 285-301. Patwardhan, A. R. (2016). Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest: Challenges and Solutions.INQUIRY: The Journal of Health Care Organization, Provision, and Financing,53, 0046958016667597. Reddi, A. (2013). New guidelines for the disclosure of academic-industry financial ties and modeling professionalism during medical education.JAMA pediatrics,167(12), 1091-1092. Ridic, G., Gleason, S., Ridic, O. (2012). Comparisons of health care systems in the United States, Germany and Canada.Materia socio-medica,24(2), 112. Stamatakis, E., Weiler, R., Ioannidis, J. (2013). Undue industry influences that distort healthcare research, strategy, expenditure and practice: a review.European journal of clinical investigation,43(5), 469-475. Www.accc.gov.au. (2017).ACCC proposes to strengthen new individual reporting in pharmaceutical code.Australian Competition and Consumer Commission. Retrieved 2 November 2017, from https://www.accc.gov.au/media-release/accc-proposes-to-strengthen-new-individual-reporting-in-pharmaceutical-code Www.ama-assn.org. (2017).Physician Financial Transparency Reports | Sunshine Act | AMA.Ama-assn.org. Retrieved 2 November 2017, from https://www.ama-assn.org/practice-management/physician-financial-transparency-reports-sunshine-act Www.cbc.ca. (2017).Ontario bill would require disclosure of pharmaceutical payments to health professionals.CBC News. Retrieved 2 November 2017, from https://www.cbc.ca/news/canada/toronto/ontario-bill-would-require-disclosure-of-pharmaceutical-payments-to-health-professionals-1.4308278 Www.ipsen.com. (2017).Cite a Website - Cite This For Me.Ipsen.com. Retrieved 2 November 2017, from https://www.ipsen.com/wp-content/uploads/2016/04/IPSEN_DDR_2015_VA.pdf Www.researchgate.net. (2017). Retrieved 2 November 2017, from https://www.researchgate.net/publication/286517835 Www.sec.gov. (2017).SEC Charges Johnson Johnson With Foreign Bribery.Sec.gov. Retrieved 2 November 2017, from https://www.sec.gov/news/press/2011/2011-87.htm

Burger King vs Mcdonalds free essay sample

The battle of the battle of creating a better burger has been going on since businesses began to sell hamburgers and compete with other businesses selling the same product. To create the better burger is the goal of any business that sells burgers since having the best will draw in customers, increase sales, and help to establish repeat business. It seems that in the past couple of decades there has been a battle of the burgers with two worldwide established fast food restaurants between the McDonalds franchise verses the Burger King franchise. These two companies have been competing in marketing and product sales for more than the past thirty years. Both McDonalds and Burger King have their own signature burger for which the different franchises are known for; the Big Mac to represent McDonald’s whereas the Whopper represents Burger King. So goes the battle of the burger between McDonald’s and Burger King, Big Mac in opposition to the Whopper which one will draw in the customers and help the franchise to corner the burger market. We will write a custom essay sample on Burger King vs Mcdonalds or any similar topic specifically for you Do Not WasteYour Time HIRE WRITER Only 13.90 / page Both franchises offer fast and friendly service, with the options to dine in the restaurant or chose the drive thru. When considering two options of a quick burger while on the go, the Big Mac sandwich from McDonalds or the Whopper sandwich from Burger King, I feel that the Whopper is a better choice. Even though the calories are high in both the Big Mac and the Whopper I think that the Whopper is a healthier as well as better tasting choice of the two different burgers.